How To Reduce Hiring Bias Against Women? Study Finds Key Role For HR
A new study reveals an effective way to reduce gender bias in hiring: shift initial application review and shortlisting ...
Can AI Fix Succession Planning?
Succession planning is part art, part science, and largely politics and bias. Can artificial intelligence improve the process ...
Immuneering Announces Clinical Supply Agreement with Regeneron Pharmaceuticals to Evaluate IMM-1-104 in Combination with Libtayo® (cemiplimab)
Immuneering plans to evaluate IMM-1-104 in combination with Libtayo in patients with advanced non-small cell lung cancer in its ongoing Phase ...
Aspen Daily News2d
Candidates express ideas on entrance to Aspen
Part two of the Aspen Daily News’ questions to six candidates for Aspen City Council focuses on the entrance to Aspen ...
Matinas BioPharma Announces Agreement for the Acquisition of Preferred Stock and Appointment of Dr. Robin L. Smith to the Board of Directors
The funds will be used for general corporate purposes, with a focus on reducing operating expenses and exploring strategic alternatives for MAT2203, the Company’s Phase 3-ready antifungal drug ...
Pharmabiz14d
Draft standard evaluation protocol released for performance evaluation of hMPV real-time PCR
Draft standard evaluation protocol released for performance evaluation of hMPV real-time PCR: Gireesh Babu, New Delhi Friday, January 31, 2025, 08:00 Hrs [IST] The Central Drugs S ...
Benefits Pro2d
Return to office, skills-based hiring, and DEI rollbacks: What’s next for HR?
By addressing challenges with thoughtful, employee-focused strategies, HR professionals can turn potential obstacles into ...
The Macomb Daily on MSN1d
Nominations now being accepted for the 2025 Athena Awards
The Athena awards are presented to women and men who have demonstrated a commitment to excellence and mentorship in their ...
Legal Restrictions Governing Artificial Intelligence in the Workplace
"In this article, we provide an overview of the federal regulatory guidance and the state and local rules in place so far. We ...
TransCode Therapeutics, Inc.: TransCode Therapeutics Announces Completion of Cohort 3 Initial Dosing with Lead Candidate in Phase 1 Clinical Trial
No significant safety or dose limiting toxicities reported PK data from Cohorts 1 and 2 consistent with preclinical and Phase 0 trial results BOSTON, Feb. 6 ...